M. Heinelt

Shattering barriers toward clinically meaningful MSC therapies

J. Karp, K. Shah, R. Abdi, 2020, Science Advances.

Cell therapy - showing cells the way home

J. Karp, O. Levy, M. Heinelt, 2015, Oncotarget.

Abstract 2067: Attacking prostate cancer with a prodrug-doped cellular Trojan horse

J. Karp, J. Isaacs, N. Bhowmick, 2016 .

A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer.

J. Karp, J. Isaacs, N. Bhowmick, 2016, Biomaterials.

A cell-based drug delivery platform for treating central nervous system inflammation

J. Karp, F. Quintana, Zhixiang Tong, 2021, Journal of Molecular Medicine.